Putnam Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$4.4M Buy
159,793
+6,953
+5% +$168K 0.01% 467
2023
Q3
$3.41M Sell
152,840
-1,900
-1% -$48.9K 0.01% 542
2023
Q2
$3.94M Buy
154,740
+7,703
+5% +$187K 0.01% 511
2023
Q1
$3.28M Sell
147,037
-36,406
-20% -$880K 0.01% 577
2022
Q4
$4.35M Sell
183,443
-13,800
-7% -$321K 0.01% 472
2022
Q3
$3.27M Buy
197,243
+21,004
+12% +$473K 0.01% 574
2022
Q2
$3.51M Buy
+176,239
New +$3.56M 0.01% 575
2022
Q1
Sell
-105,916
Closed -$4.36M 1263
2021
Q4
$4.36M Buy
105,916
+6,163
+6% +$272K 0.01% 590
2021
Q3
$4.63M Sell
99,753
-25
-0% -$1.09K 0.01% 544
2021
Q2
$3.99M Sell
99,778
-3,145
-3% -$134K 0.01% 575
2021
Q1
$5.53M Sell
102,923
-3,883
-4% -$224K 0.01% 477
2020
Q4
$5.23M Sell
106,806
-777
-0.7% -$36K 0.01% 491
2020
Q3
$3.5M Sell
107,583
-190
-0.2% -$6.04K 0.01% 541
2020
Q2
$2.79M Buy
107,773
+4,235
+4% +$106K 0.01% 586
2020
Q1
$2.52M Sell
103,538
-325
-0.3% -$8.18K 0.01% 556
2019
Q4
$2.9M Buy
103,863
+3,675
+4% +$95.1K 0.01% 667
2019
Q3
$2.4M Buy
+100,188
New +$2.67M 0.01% 683

Other funds holding VCYT

Putnam Investments's VCYT Position: Q4 2023 in Review

Putnam Investments increased its Veracyte (VCYT) stake by 4.5% in Q4 2023, buying an estimated $168K and bringing the position to 159,793 shares worth $4.4M. The position accounts for 0.01% of the portfolio, ranked #467.

Putnam Investments first reported a position in VCYT in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.53M in Q1 2021. 250 funds tracked by Wall St. Rank hold VCYT as of Q4 2023.

  • Putnam Investments held 159,793 shares of Veracyte worth $4.4M as of Q4 2023.
  • Putnam Investments bought 6,953 Veracyte shares in Q4 2023, an estimated $168K.
  • Veracyte made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #467 holding.
  • Putnam Investments first reported a position in Veracyte in Q3 2019 and has held it in 17 quarters since.
  • Putnam Investments's Veracyte position peaked at $5.53M in Q1 2021.
  • 250 funds tracked by Wall St. Rank held Veracyte as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.